Skip to main content
Top
Published in: Tumor Biology 1/2014

01-01-2014 | Research Article

Association of Kaposi’s sarcoma-associated herpesvirus (KSHV) with bladder cancer in Croatian patients

Authors: Martina Paradžik, Viljemka Bučević-Popović, Marijan Šitum, Crystal J. Jaing, Marina Degoricija, Kevin S. McLoughlin, Said I. Ismail, Volga Punda-Polić, Janoš Terzić

Published in: Tumor Biology | Issue 1/2014

Login to get access

Abstract

As the seventh most common human malignancy, bladder cancer represents a global health problem. In addition to well-recognized risk factors such as smoking and exposure to chemicals, various infectious agents have been implicated as cofactors in the pathogenesis of urothelial malignancies. The aim of the present study was to assess the possible association of viral infection and bladder cancer in Croatian patients. Biopsy specimens were collected from a total of 55 patients diagnosed with different stages of bladder cancer. Initial screening of DNA extracts for the presence of viruses on Lawrence Livermore Microbial Detection Array revealed Kaposi’s sarcoma-associated herpesvirus (KSHV) in each of three randomly chosen biopsy specimens. The prevalence of infection with KSHV among study population was then examined by KSHV-specific polymerase chain reaction (PCR) and immunoblotting. By nested PCR, KSHV DNA was detected in 55 % of patients. KSHV, also known as human herpesvirus 8, is an infectious agent known to cause cancer. Its oncogenic potential is primarily recognized from its role in Kaposi’s sarcoma, but it has also been involved in pathogenesis of two lymphoproliferative disorders. A high prevalence of KSHV infection in our study indicates that KSHV may play a role in tumorigenesis of bladder cancer and warrants further studies.
Literature
1.
go back to reference Bray F, Jian-Song R, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133–45.PubMedCrossRef Bray F, Jian-Song R, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133–45.PubMedCrossRef
6.
7.
go back to reference Bedwani R, Renganathan E, El Kwhskyl F, Braga C, Abu Seif HH, Amul Azm T, et al. Schistosomiasis and the risk of bladder cancer in Alexandria. Egypt Br J Cancer. 1998;77:1186–9.CrossRef Bedwani R, Renganathan E, El Kwhskyl F, Braga C, Abu Seif HH, Amul Azm T, et al. Schistosomiasis and the risk of bladder cancer in Alexandria. Egypt Br J Cancer. 1998;77:1186–9.CrossRef
8.
go back to reference Zaghloul MS. Bladder cancer and schistosomiasis. J Egypt Natl Cancer Inst. 2012;24:151–9.CrossRef Zaghloul MS. Bladder cancer and schistosomiasis. J Egypt Natl Cancer Inst. 2012;24:151–9.CrossRef
9.
go back to reference Barghi MR, Hajimohammadmehdiarbab A, Moghaddam SM, Kazemi B. Correlation between human papillomavirus infection and bladder transitional cell carcinoma. BMC Infect Dis. 2005;5:102.PubMedCentralPubMedCrossRef Barghi MR, Hajimohammadmehdiarbab A, Moghaddam SM, Kazemi B. Correlation between human papillomavirus infection and bladder transitional cell carcinoma. BMC Infect Dis. 2005;5:102.PubMedCentralPubMedCrossRef
10.
go back to reference Li N, Yang L, Zhang Y, Zhao P, Zheng T, Dai M. Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis. 2011;204:217–23.PubMedCrossRef Li N, Yang L, Zhang Y, Zhao P, Zheng T, Dai M. Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis. 2011;204:217–23.PubMedCrossRef
11.
go back to reference Alexiev BA, Randhawa P, Vazquez Martul E, Zeng G, Luo C, Ramos E, et al. BK virus-associated urinary bladder carcinoma in transplant recipients: report of 2 cases, review of the literature, and proposed pathogenic model. Hum Pathol. 2013;44(5):908–17. doi:10.1016/j.humpath.2012.09.019.PubMedCrossRef Alexiev BA, Randhawa P, Vazquez Martul E, Zeng G, Luo C, Ramos E, et al. BK virus-associated urinary bladder carcinoma in transplant recipients: report of 2 cases, review of the literature, and proposed pathogenic model. Hum Pathol. 2013;44(5):908–17. doi:10.​1016/​j.​humpath.​2012.​09.​019.PubMedCrossRef
12.
go back to reference Badawi H, Ahmed H, Aboui Fadi L, Helmi A, Fam N, Diab M, et al. Herpes simplex virus type-2 in Egyptian patients with bladder cancer of cystitis. APMIS. 2009;118:37–44.CrossRef Badawi H, Ahmed H, Aboui Fadi L, Helmi A, Fam N, Diab M, et al. Herpes simplex virus type-2 in Egyptian patients with bladder cancer of cystitis. APMIS. 2009;118:37–44.CrossRef
13.
go back to reference Escudero AL, Luque RJ, Quintero A, Alvarez-Kindelan J, Requena MJ, Montironi R, et al. Association of human herpesvirus type 6 DNA with human bladder cancer. Cancer Lett. 2005;230:20–4.PubMedCrossRef Escudero AL, Luque RJ, Quintero A, Alvarez-Kindelan J, Requena MJ, Montironi R, et al. Association of human herpesvirus type 6 DNA with human bladder cancer. Cancer Lett. 2005;230:20–4.PubMedCrossRef
14.
go back to reference Monini P, De Lelis L, Fabris M, Rigolin F, Cassai E. Kaposi’s sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med. 1996;334:1168–72.PubMedCrossRef Monini P, De Lelis L, Fabris M, Rigolin F, Cassai E. Kaposi’s sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med. 1996;334:1168–72.PubMedCrossRef
15.
go back to reference Panagiotakis GI, Papadogianni D, Chatziioannou MN, Lasithiotaki I, Delakas D, Spandidos DA. Association of human herpes, papilloma and polyoma virus families with bladder cancer. Tumor Biol. 2013;34:71–9.CrossRef Panagiotakis GI, Papadogianni D, Chatziioannou MN, Lasithiotaki I, Delakas D, Spandidos DA. Association of human herpes, papilloma and polyoma virus families with bladder cancer. Tumor Biol. 2013;34:71–9.CrossRef
16.
go back to reference Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266:1865–9.PubMedCrossRef Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266:1865–9.PubMedCrossRef
17.
go back to reference Cohen A, Wolf DG, Guttman-Yassky E, Sarid R. Kaposi’s sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects. Crit Rev Clin Lab Sci. 2005;42:101–53.PubMedCrossRef Cohen A, Wolf DG, Guttman-Yassky E, Sarid R. Kaposi’s sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects. Crit Rev Clin Lab Sci. 2005;42:101–53.PubMedCrossRef
18.
go back to reference Wen KW, Damania B. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett. 2010;289:140–50.PubMedCrossRef Wen KW, Damania B. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett. 2010;289:140–50.PubMedCrossRef
19.
20.
21.
go back to reference De Oliveira DE, Ballon G, Cesarman E. NF-κB signaling modulation by EBV and KSHV. Trends Microbiol. 2010;18:248–57.PubMedCrossRef De Oliveira DE, Ballon G, Cesarman E. NF-κB signaling modulation by EBV and KSHV. Trends Microbiol. 2010;18:248–57.PubMedCrossRef
22.
go back to reference Ganem D. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Investig. 2010;120:939–49.PubMedCrossRef Ganem D. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Investig. 2010;120:939–49.PubMedCrossRef
23.
go back to reference Cattani P, Cerimele F, Porta D, Graffeo R, Ranno S, Marchetti S, et al. Age-specific seroprevalence of human herpesvirus 8 in Mediterranean regions. Clin Microbiol Infect. 2003;9:274–9.PubMedCrossRef Cattani P, Cerimele F, Porta D, Graffeo R, Ranno S, Marchetti S, et al. Age-specific seroprevalence of human herpesvirus 8 in Mediterranean regions. Clin Microbiol Infect. 2003;9:274–9.PubMedCrossRef
24.
go back to reference Mesri EA, Cesarman E, Boshoff C. Kaposi’s sarcoma and its associated herpesvirus. Nat Rev Cancer. 2010;10:707–19.PubMedCrossRef Mesri EA, Cesarman E, Boshoff C. Kaposi’s sarcoma and its associated herpesvirus. Nat Rev Cancer. 2010;10:707–19.PubMedCrossRef
25.
26.
go back to reference Erlandsson L, Rosenstierne MW, Jaing C, McLoughlin K, Gardner S, Fomsgaard A. The microbial detection array combined with random Phi29 amplification used as a diagnostic tool for unbiased virus detection in clinical samples. PLoS One. 2011;6:e22631.PubMedCentralPubMedCrossRef Erlandsson L, Rosenstierne MW, Jaing C, McLoughlin K, Gardner S, Fomsgaard A. The microbial detection array combined with random Phi29 amplification used as a diagnostic tool for unbiased virus detection in clinical samples. PLoS One. 2011;6:e22631.PubMedCentralPubMedCrossRef
27.
go back to reference Pan L, Milligan L, Michaeli J, Cesarman E, Knowles DM. Polymerase chain reaction detection of Kaposi’s sarcoma-associated herpesvirus-optimized protocols and their application to myeloma. J Mol Diagn. 2001;3:32–8.PubMedCentralPubMedCrossRef Pan L, Milligan L, Michaeli J, Cesarman E, Knowles DM. Polymerase chain reaction detection of Kaposi’s sarcoma-associated herpesvirus-optimized protocols and their application to myeloma. J Mol Diagn. 2001;3:32–8.PubMedCentralPubMedCrossRef
28.
go back to reference Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat Immunol. 2011;12:715–23.PubMedCrossRef Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat Immunol. 2011;12:715–23.PubMedCrossRef
Metadata
Title
Association of Kaposi’s sarcoma-associated herpesvirus (KSHV) with bladder cancer in Croatian patients
Authors
Martina Paradžik
Viljemka Bučević-Popović
Marijan Šitum
Crystal J. Jaing
Marina Degoricija
Kevin S. McLoughlin
Said I. Ismail
Volga Punda-Polić
Janoš Terzić
Publication date
01-01-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 1/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1079-2

Other articles of this Issue 1/2014

Tumor Biology 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine